| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.04B | 1.02B | 979.24M | 1.10B | 1.21B |
| Gross Profit | 243.30M | 243.54M | 233.23M | 257.10M | 248.81M |
| EBITDA | 109.98M | 129.34M | 140.78M | 106.23M | 122.35M |
| Net Income | 30.68M | 39.92M | 51.01M | 66.29M | 54.07M |
Balance Sheet | |||||
| Total Assets | 1.58B | 1.53B | 1.63B | 1.57B | 1.72B |
| Cash, Cash Equivalents and Short-Term Investments | 157.68M | 115.71M | 90.58M | 78.61M | 68.44M |
| Total Debt | 602.28M | 572.36M | 615.00M | 549.90M | 670.64M |
| Total Liabilities | 805.58M | 739.71M | 786.47M | 682.49M | 794.28M |
| Stockholders Equity | 779.32M | 800.14M | 851.63M | 896.41M | 917.79M |
Cash Flow | |||||
| Free Cash Flow | 294.58M | 364.68M | 356.93M | 394.82M | 244.57M |
| Operating Cash Flow | 322.33M | 393.65M | 384.18M | 421.59M | 270.18M |
| Investing Cash Flow | -18.36M | 13.42M | -26.29M | -38.50M | -14.74M |
| Financing Cash Flow | -320.94M | -378.34M | -342.89M | -368.40M | -234.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$518.45M | 11.45 | 6.48% | 8.33% | -11.73% | -69.83% | |
73 Outperform | HK$367.40M | 3.03 | 20.13% | ― | -1.25% | -36.93% | |
72 Outperform | HK$289.30M | 9.71 | 3.92% | 10.32% | 2.75% | -21.60% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
55 Neutral | HK$363.93M | 6.45 | 10.20% | ― | 23.29% | 9.11% | |
52 Neutral | HK$91.71M | 27.02 | 2.58% | ― | 8.10% | -36.36% | |
40 Underperform | HK$139.75M | -5.88 | -27.00% | ― | 10.42% | 11.14% |